Print

Aastrom Biosciences, Inc. (ASTM) to Present at the 23rd Annual Oppenheimer Healthcare Conference  
12/10/2012 9:06:14 AM

ANN ARBOR, Mich., Dec. 10, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that Chief Commercial Officer Dan Orlando will present at the 23rd Annual Oppenheimer Healthcare Conference at the Waldorf Astoria in New York City.
//-->